Advisors Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $290K | Sell |
13,467
-3,977
| -23% | -$85.8K | 0.01% | 1058 |
|
|
2025
Q1 | $290K | Sell |
17,444
-3,408
| -16% | -$56.6K | 0.01% | 1053 |
|
|
2024
Q4 | $383K | Sell |
20,852
-235
| -1% | -$4.31K | 0.01% | 984 |
|
|
2024
Q3 | $324K | Buy |
21,087
+2,499
| +13% | +$38.4K | 0.01% | 1021 |
|
|
2024
Q2 | $302K | Buy |
18,588
+4,332
| +30% | +$70.4K | 0.01% | 1026 |
|
|
2024
Q1 | $264K | Buy |
14,256
+6,019
| +73% | +$111K | 0.01% | 1079 |
|
|
2023
Q4 | $258K | Buy |
8,237
+244
| +3% | +$7.64K | 0.01% | 1074 |
|
|
2023
Q3 | $167K | Buy |
7,993
+5,982
| +297% | +$125K | ﹤0.01% | 1135 |
|
|
2023
Q2 | $48.2K | Buy |
+2,011
| New | +$48.2K | ﹤0.01% | 1287 |
|
|
2023
Q1 | – | Sell |
-1,892
| Closed | -$30.1K | – | 1448 |
|
|
2022
Q4 | $30.1K | Sell |
1,892
-22,046
| -92% | -$351K | ﹤0.01% | 1394 |
|
|
2022
Q3 | $392K | Sell |
23,938
-553
| -2% | -$9.06K | 0.01% | 983 |
|
|
2022
Q2 | $345K | Sell |
24,491
-3,706
| -13% | -$52.2K | 0.01% | 1039 |
|
|
2022
Q1 | $683K | Sell |
28,197
-1,862
| -6% | -$45.1K | 0.01% | 916 |
|
|
2021
Q4 | $702K | Sell |
30,059
-476
| -2% | -$11.1K | 0.01% | 912 |
|
|
2021
Q3 | $507K | Sell |
30,535
-232
| -0.8% | -$3.85K | 0.01% | 988 |
|
|
2021
Q2 | $750K | Buy |
30,767
+2,365
| +8% | +$57.7K | 0.01% | 911 |
|
|
2021
Q1 | $733K | Buy |
28,402
+13,414
| +89% | +$346K | 0.01% | 919 |
|
|
2020
Q4 | $801K | Buy |
14,988
+11,331
| +310% | +$606K | 0.01% | 836 |
|
|
2020
Q3 | $151K | Buy |
3,657
+1,694
| +86% | +$69.9K | ﹤0.01% | 1238 |
|
|
2020
Q2 | $95K | Buy |
+1,963
| New | +$95K | ﹤0.01% | 1310 |
|
|
2018
Q3 | – | Sell |
-9,897
| Closed | -$151K | – | 1575 |
|
|
2018
Q2 | $151K | Sell |
9,897
-1,621
| -14% | -$24.7K | ﹤0.01% | 1296 |
|
|
2018
Q1 | $287K | Sell |
11,518
-542
| -4% | -$13.5K | ﹤0.01% | 1174 |
|
|
2017
Q4 | $363K | Sell |
12,060
-1,198
| -9% | -$36.1K | 0.01% | 1135 |
|
|
2017
Q3 | $499K | Sell |
13,258
-1,351
| -9% | -$50.8K | 0.01% | 1059 |
|
|
2017
Q2 | $407K | Sell |
14,609
-579
| -4% | -$16.1K | 0.01% | 1148 |
|
|
2017
Q1 | $522K | Sell |
15,188
-824
| -5% | -$28.3K | 0.01% | 1084 |
|
|
2016
Q4 | $462K | Buy |
16,012
+6,866
| +75% | +$198K | 0.01% | 1145 |
|
|
2016
Q3 | $291K | Buy |
+9,146
| New | +$291K | ﹤0.01% | 1252 |
|